This webinar explores how automation strategies and control schemes facilitate rapid analytical results, crucial for managing glycosylation variability that affects product quality. The MAST® Autosampling Solution and Agilent 2D-LC/TOF MS was used to enable glycosylation monitoring during perfusion cell culture. A digital lab infrastructure and cloud-based orchestration layer managed communication and control between the units, allowing easy modification of parameters like target galactosylation and sampling frequency. Over a 35-day culture process, targeted galactosylation setpoints were maintained within a ± 2% deadband, ensuring efficient data collection and timely insights.
In this webinar, you will learn:
- Current limitations in conventional sampling and analytical methods
- The role of automated sampling in enhancing process control
- How digital technologies and PAT are integrated to drive bioprocess innovation
- About case studies for on-line glycosylation monitoring
Speaker

Srijana Chapagain
Merck
PAT & Digital Applications
Srijana Chapagain is an applications engineer within the single-use and integrated systems PAT (Process Analytical Technology) & digital applications team. She joined Merck in 2020 and was previously a part of the SU&IS upstream applications team. In her role, Srijana has been involved in various product development initiatives and technology assessments within the upstream bioprocessing and (PAT)-enabling sector. Her current focus encompasses PAT integration and the digital transformation of laboratory operations. Srijana holds a B.Sc. in chemical engineering from Villanova University and a M.Sc. in engineering management from Tufts University.
Pharma and biopharma manufacturing
- Pharma and biopharma manufacturing
Duration:1h
Language:English
Session 1:Thu, July 31, 2025 10:00 AM ET
To continue reading please sign in or create an account.
Don't Have An Account?